Header
SABPA Newsletter, January 2018
In This Issue
Upcoming Events
SABPA Frontiers in Technology and Diagnostics Forum
Connect With Us
 
Subscribe to our WeChat 

SABPA Annoucement

Happy New Year!
Season’s greetings from SABPA.
We wish you a very happy and prosperous New Year!
The second annual SABPA Frontiers in Technology and Diagnostics (FTD) Forum is just around the corner. On-line registration is already open. Take advantage of the early bird discount to register now!

SABPA Events
The 2nd Annual SABPA Frontiers in Therapeutics and Diagnostics (FTD) Forum
Date: Saturday, February 10, 2018
Location: Hilton San Diego/Del Mar, 15575 Jimmy Durante Blvd, Del Mar, CA

Community Events
WuXi Global Forum 2018 (A Celebration of Global Partnerships)
Now in its sixth year, the WuXi Global Forum during the J.P. Morgan Healthcare Conference brings together more than 2,000 industry leaders to promote new thinking on a global stage as we strive to provide transformative models and solutions for patients. During this captivating forum, thought leaders will discuss the rapid advances and changes impacting the industry, from the most disruptive therapeutic interventions to artificial intelligence to the evolving global regulatory landscape.
Date and Time: 3:00-6:00 PM Pacific Standard Time, Jan 9, 2018
Please register here to join us for a complimentary live global webcast.
3:00-3:10PM WELCOME
Host: Hui Cai, Forum Chair and Head of Communications, WuXi AppTec
Jim Greenwood, President and CEO, Biotechnology Innovation Organization (BIO)
3:10-3:20PM OPENING REMARKS
Ge Li, Chairman and CEO, WuXi AppTec
3:20-4:00PM BETTING ON THE BEST
From Novartis’ revolutionary cancer treatment, to Celgene’s bold pursuit in science, and to Atlas’ launching of big idea companies, industry leaders will share perspectives on pushing the boundaries of innovation, and what’s coming next.
Moderator: Edward Hu, CFO and CIO, WuXi AppTec
Jay Bradner, President of Novartis Institute for Biomedical Research (NIBR)
Rupert Vessey, President of Research and Early Development, Celgene
Bruce Booth, Partner, Atlas Venture
4:00-4:20PM SPOTLIGHT ON CHINA REGULATORY REFORM
China’s Food and Drug Administration has introduced landmark reforms in 2017 to accelerate new drug approval, which are likely to be a game changer for companies that want to bring innovative products to the world’s second-largest pharmaceutical market more quickly.
Moderator: Steve Yang, EVP, CBO and CSO, WuXi AppTec
A special guest speaker from CDE/CFDA
4:20-5:00PM LAUNCHPAD 2017
The hurdles could not be higher for young companies working on diseases that have taken their toll even amongst the most experienced drug hunters. This panel takes a closer look at four startup all-stars on how they are tackling tough diseases through unique lenses, and launching a new generation of disruptive therapeutic intervention.
Moderator: Kristina Burow, Managing Director, ARCH Venture Partners
Barbara Weber, CEO of Tango Therapeutics; Venture Partner of Third Rock Ventures
Sandy Macrae, President and CEO, Sangamo Therapeutics
Geoffrey von Maltzahn, Co-Founder and Chief Innovation Officer, Kaleido Biosciences
Bill Doyle, Executive Chairman of Novocure; Managing Director of WFD Ventures
5:00-5:50PM IS THE FUTURE HERE?
Data. Artificial Intelligence. Deep Learning. What do they really mean? How will they change the future of drug discovery and development? How will they change the way we predict, prevent, diagnose, and treat diseases? And, are we ready?
Moderator: David Beier, Managing Director, Bay City Capital
Jessica Mega, Chief Medical Officer, Verily Life Sciences
Vijay Pande, General Partner, Andreessen Horowitz
Atul Butte, Priscilla Chan and Mark Zuckerberg Professor and Director, UCSF
Mickey Kertesz, CEO, Karius
Alex Zhavoronkov, CEO, Insilico Medicine
5:50-6:00PM CLOSING
Peter Winter, Editor, Clarivate/BioWorld Insight
Biotech Showcase™ 2018
 
Date:  January 8-10, 2018
Venue:
Hilton San Francisco Union Square
Registration:
Organizers:   Demy-Colton Life Science Advisors and EBD Group, Inc.
 
Key words:
Investor conference, investor, venture capital, private equity, biotech, pharmaceutical, life science, diagnostic partnering, business development, licensing, finance
Short description:
Biotech Showcase™ is an investor and partnering conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives during the course of one of the largest annual healthcare conferences that attracts investors and biopharmaceutical executives from around the world.
The 2017 event showed a substantial increase in the number of presenting companies, as well as significant growth in the number of attendees and one-to-one meetings. Now in its tenth year, Biotech Showcase 2017 is expected to feature presentations by close to 400 public and private companies and attract more than 3,000 attendees. The event will run a full program of topical plenary sessions and workshops, including special-focus events dedicated to emerging trends.
The demand for innovation in all areas of human health is the impetus behind Digital Medicine & Medtech Showcase, a focus event taking place during Biotech Showcase at Parc 55 in San Francisco. The event brings together key stakeholders at the convergence of traditional therapeutics, digital tools, combination products, companion diagnostics, precision medicine, AI and other technical advances to explore funding opportunities, partnerships and collaboration.
Biotech Showcase is co-produced by Demy-Colton Life Science Advisors and EBD Group. Both organizations have a long history of providing high quality business support services to the biotechnology industry.
Download China Showcase event flyer here!
China Showcase
 
Date:  January 7, 2018
Venue:
Parc 55 San Francisco – A Hilton Hotel,
San Francisco, CA
Registration:
SABPA discount code: “SABPA” for USD 100 off the registration rate.
Register at Chinashowcase.com

Our Platinum Corporate Sponsors

Our Gold Corporate Sponsors
About SABPA
Sino-American Biotechnology and Pharmaceutical Professionals Association (SABPA) is an 501(c)(3) nonprofit organization founded in early 2002 by professionals and scholars from the Chinese community in San Diego. In 2005, we expanded to Orange County and Los Angeles. We invite all scholars, professionals and entrepreneurs of any origin who are working in, engaged in, or interested in the biotech and pharmaceutical industry in Southern California to join us as a member of SABPA.
Our Mission
  • Provide a forum to facilitate professional contact and communication among local Chinese American professionals in academia, biotech and pharmaceutical industries;
  • Foster professional growth, career improvement and personal development of our members;
  • Provide opportunities to educate local communities about the values of biomedical research and the benefits of biotech and pharmaceutical innovations;
  • Stimulate and facilitate the development of relationships between the U.S. and China in biotech and pharmaceutical communities.
  • To fulfill our mission, we will sponsor professional seminars, meetings, and symposia; share employment opportunity information in local biotech and pharmaceutical industry; sponsor social events; and disseminate information about local biotech and pharmaceutical companies.